Related Experiment Video
Updated: May 12, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Interplay between coagulation and vascular inflammation in sickle cell disease
Erica Sparkenbaugh1, Rafal Pawlinski
1Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, NC 27599, USA.
British Journal of Haematology
|April 19, 2013
Summary
Sickle cell disease involves red blood cell sickling and vaso-occlusion. New research highlights the roles of hemolytic anemia, vasculopathy, and hypercoagulable states in disease progression and vascular inflammation.
Area of Science:
- Hematology
- Vascular Biology
- Coagulation Science
Background:
- Sickle cell disease (SCD) is a common inherited blood disorder causing organ damage.
- While red blood cell sickling and vaso-occlusion are key, hemolytic anemia and vasculopathy are increasingly recognized.
- A hypercoagulable state, involving both coagulation pathways, is a significant feature of SCD.
Purpose of the Study:
- To summarize the roles of vascular inflammation and coagulation activation in SCD.
- To discuss potential mechanisms driving coagulation activation in SCD.
- To review evidence on the interplay between coagulation and vascular inflammation in SCD.
Main Methods:
- Literature review and data synthesis.
- Analysis of existing research on SCD pathophysiology.
- Focus on coagulation pathways and vascular inflammation mechanisms.
Main Results:
- Coagulation activation contributes to thrombotic complications in SCD.
- Coagulation activation is implicated in the vascular inflammation associated with SCD.
- Evidence shows a significant crosstalk between coagulation and vascular inflammation in SCD.
Conclusions:
- Understanding the interaction between coagulation and vascular inflammation is crucial for managing SCD.
- Targeting these pathways may offer new therapeutic strategies for SCD.
- Further research is needed to elucidate the complex mechanisms involved.
Related Concept Videos
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:25Acute Inflammation II: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.